Circulating endotoxin during initial antibiotic treatment of severe gram-negative bacteremic infections

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 270-273

  Maury, Eric ^b   Barakett, Vanda ^b   Blanchard, Hervé ^b   Guitton, Christophe ^b   Fitting, Catherine ^b   Vassal, Thierry ^b   Chauvin, Pierre ^b   Guidet, Bertrand ^b   Offenstadt, Georges ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CYTOKINE; ENDOTOXIN; ERYTHROMYCIN; GENTAMICIN; INTERLEUKIN 6; INTERLEUKIN 8; OFLOXACIN; PEFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOKINE PRODUCTION; ENDOTOXEMIA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOPATHOGENESIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; SEPTIC SHOCK; TREATMENT OUTCOME;

EID: 0031846425     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517451     Document Type: Article

References (15)

1. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991;115:457-69.
2. Dofferhoff ASM, Potthoff H, Bom VJJ, et al. The release of endotoxin, TNF, and IL-6 during the antibiotic treatment of experimental Gram-negative sepsis. J Endotoxin Res 1995;2:37-44.
3. Reilly J, Compagnon A, Tournier P, Bastin R, Dubuit H. Les accidents du traitement des fièvres typhoïdes par la chloromycétine. Ann Med Interne (Paris) 1950;51:597-629.
4. Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-55.
5. Legall JR, Lemeshow S, Saulnier F. A new simplified acute physiologic score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63.
6. Guidet B, Barakett V, Vassal T, Petit JG, Offenstadt G. Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest 1994;106:1194-201.
7. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and non septic origin. Crit Care Med 1994;22:673-9.
8. Brandtzaeg P, Kierulf P, Gaustad P, et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989;159:195-204.
9. Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJH, Speelman P. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995;172:886-91.
10. Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchnern DF. Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis 1988;157:565-8.
11. Dofferhoff ASM, Bom VJJ, de Vries-Hospers, et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992;20:185-92.
12. Morrison DC, Bucklin SE. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental Gram-negative sepsis. Scand J Infect Dis Suppl 1996;101:3-8.
13. Prins JM, van Deventer SJH, Kuijper ED, Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994;38:1211-8.
14. Jackson JJ, Kropp H. β-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2 - specific imipenem and PBP3-specific ceftazidime. J Infect Dis 1992;165:1033-41.
15. Hesse DG, Tracey KJ, Fong Y, Beutler B, Cerami A. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988;166:147-53.